Self-administered icatibant in a patient with hereditary angioedema type I

被引:0
|
作者
Wiednig, M. [1 ]
机构
[1] Med Univ Graz, Dept Environm Dermatol & Venerol, Graz, Austria
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
915
引用
收藏
页码:352 / 352
页数:1
相关论文
共 50 条
  • [31] Hereditary angioedema type I in a female patient: a case report
    Prkacin, Ingrid
    Ban, Ana
    Cavric, Gordana
    Hamp, Dubravka Bartolek
    [J]. Signa Vitae, 2014, 9 : 97 - 98
  • [32] LONGITUDINAL NATURAL HISTORY OF PATIENTS WITH TYPE I/II HEREDITARY ANGIOEDEMA: ICATIBANT OUTCOME SURVEY DATA
    Maurer, M.
    Caballero, T.
    Aberer, W.
    Zanichelli, A.
    Bouillet, L.
    Bygum, A.
    Grumach, A.
    Pommie, C.
    Andresen, I.
    Longhurst, H.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S42 - S43
  • [33] Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
    Bygum, Anette
    Caballero, Teresa
    Grumach, Anete S.
    Longhurst, Hilary J.
    Bouillet, Laurence
    Aberer, Werner
    Zanichelli, Andrea
    Botha, Jaco
    Andresen, Irmgard
    Maurer, Marcus
    Grumach, A. S.
    Bygum, A.
    Delaunay, C. Blanchard
    Boccon-Gibod, I
    Bouillet, L.
    Coppere, B.
    Du Thanh, A.
    Dzviga, C.
    Fain, O.
    Goichot, B.
    Gompel, A.
    Guez, S.
    Jeandel, P. Y.
    Kanny, G.
    Launay, D.
    Maillard, H.
    Martin, L.
    Masseau, A.
    Ollivier, Y.
    Sobel, A.
    Aygoeren-Puersuen, E.
    Bas, M.
    Bauer, M.
    Bork, K.
    Greve, J.
    Magerl, M.
    Martinez-Saguer, I
    Maurer, M.
    Strassen, U.
    Papadopoulou-Alataki, E.
    Psarros, F.
    Graff, Y.
    Kivity, S.
    Reshef, A.
    Toubi, E.
    Arcoleo, F.
    Bova, M.
    Cicardi, M.
    Nconi, P. Ma
    Marone, G.
    [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2019, 9
  • [34] MANAGEMENT OF ADULT PATIENTS WITH ICATIBANT IN HEREDITARY ANGIOEDEMA
    Drake, David
    Sultan, Laith
    [J]. EMERGENCY MEDICINE JOURNAL, 2011, 28 (08) : 720 - 721
  • [35] Treatment of submucosal hereditary angioedema attacks with icatibant
    Csuka, D.
    Zotter, Z.
    Varga, L.
    Boeroecz, Z.
    Temesszentandrasi, G.
    Jakab, L.
    Karadi, I
    Farkas, H.
    [J]. ALLERGY, 2011, 66 : 426 - 427
  • [36] Experiences with Icatibant in Adolescent Girl with Hereditary Angioedema
    Jesenak, M.
    Banovcin, P.
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S352 - S352
  • [37] Icatibant: only in the treatment of hereditary angioedema attacks?
    Fernandes, M.
    Lourenco, T.
    Spinola Santos, A.
    Lopes, A.
    Cosme, J.
    Marcelino, J.
    Ferreira, R.
    Aguiar, R.
    Pestana, L.
    Almeida, P.
    Caiado, J.
    Duarte, F.
    Neto, M.
    Costa, A. C.
    Alonso, E.
    Branco Ferreira, M.
    Pedro, E.
    Barbosa, M.
    [J]. ALLERGY, 2017, 72 : 452 - 452
  • [38] Hereditary angioedema: epidemiology, management, and role of icatibant
    Ghazi, Aasia
    Grant, J. Andrew
    [J]. BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 103 - 113
  • [39] Positive treatment outcome with icatibant in an adolescent patient with acute hereditary angioedema attack
    Bjorkander, J.
    [J]. ALLERGY, 2011, 66 : 427 - 427
  • [40] Icatibant as acute treatment for hereditary angioedema in adults
    Farkas, Henriette
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (06) : 779 - 788